Psychiatry and Neurology, Neurology · Alexandria, VA
NPI
1275859688
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1500 N Beauregard St, Suite 300
Alexandria, VA, 22311
Phone (703) 845-1500
Groups this clinician bills Medicare through
Medicare paid, 2024
$160K
2,826 services
Medicare patients, 2024
680
Average age 76
Drug cost, 2024
$5.8M
4,957 prescriptions
Company payments, 2025
$412K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramsey A Falconer was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 802 times for 466 patients. In total Ramsey A Falconer billed 2,826 services in 21 codes, and Medicare paid $160K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 802 | 466 | $13.42 | $11K |
| 99214 Office E&M - Established | Office | 564 | 383 | $77.14 | $44K |
| 99215 Office E&M - Established | Office | 551 | 353 | $114.37 | $63K |
| 99421 Office/Outpatient Services | Office | 171 | 123 | $10.80 | $1,846 |
| 95983 Electrical Nerve Conductivity | Office | 87 | 44 | $40.42 | $3,516 |
| 95874 Musculoskeletal | Office | 76 | 29 | $17.15 | $1,304 |
| 99205 Office E&M - New | Office | 74 | 74 | $138.88 | $10K |
| 99204 Office E&M - New | Office | 61 | 61 | $93.99 | $5,733 |
| 64611 Musculoskeletal | Office | 48 | 24 | $82.94 | $3,981 |
| 64616 Musculoskeletal | Office | 48 | 17 | $121.54 | $5,834 |
| 99213 Office E&M - Established | Office | 26 | 19 | $51.40 | $1,336 |
| 64642 Musculoskeletal | Office | 23 | 11 | $80.01 | $1,840 |
By year: 2022 $260K for 17,707 services; 2023 $158K for 1,557 services; 2024 $160K for 2,826 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramsey A Falconer prescribed most often to Medicare patients was Rytary (Carbidopa/Levodopa), with 812 prescriptions and refills. In total Ramsey A Falconer wrote 4,957 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rytary Carbidopa/Levodopa | 812 | 1,968 | 200 | $1.5M |
| Carbidopa-Levodopa Carbidopa/Levodopa | 480 | 1,337 | 169 | $15K |
| Propranolol Hcl Er Propranolol Hcl | 262 | 726 | 76 | $14K |
| Rasagiline Mesylate Generic | 262 | 727 | 76 | $51K |
| Nuplazid Pimavanserin Tartrate | 227 | 291 | 41 | $1.4M |
| Clonazepam Generic | 204 | 491 | 75 | $5,680 |
| Rivastigmine Generic | 186 | 460 | 58 | $65K |
| Nourianz Istradefylline | 178 | 282 | 33 | $532K |
| Donepezil Hcl Generic | 154 | 358 | 43 | $4,529 |
| Quetiapine Fumarate Generic | 152 | 347 | 46 | $2,839 |
| Primidone Generic | 144 | 387 | 37 | $4,051 |
| Gocovri Amantadine Hcl | 141 | 219 | 27 | $617K |
| Gabapentin Generic | 132 | 308 | 39 | $3,411 |
| Escitalopram Oxalate Generic | 99 | 273 | 28 | $1,333 |
| Crexont Carbidopa/Levodopa | 78 | 195 | 58 | $103K |
Brand drugs: 1,910 claims; generic drugs: 3,047 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramsey A Falconer $412K ($389K in general payments such as food, travel and fees and $23K for research) from 16 companies. The largest payer was Neurocrine BioSciences, Inc. with $154K.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 142 | $154K |
| Amneal Pharmaceuticals LLC AMRX | 55 | $103K |
| MDD US Operations, LLC | 67 | $54K |
| Merz Pharmaceuticals, LLC | 31 | $30K |
| Abbott Laboratories ABT | 34 | $23K |
| ACADIA Pharmaceuticals Inc ACAD | 21 | $17K |
| Abbvie Inc. ABBV | 19 | $14K |
| Medtronic, Inc. MDT | 5 | $11K |
| Kyowa Kirin Co., Ltd 4151.T | 1 | $5,438 |
| Supernus Pharmaceuticals, Inc. SUPN | 14 | $298 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.